Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmpeak Energy Regulatory News (AMP)

Share Price Information for Ampeak Energy (AMP)

Share Price is delayed by 15 minutes
Get Live Data
2.70    0.00 (0.00%)
Bid:
2.60
Ask:
2.80
Spread: 0.20 (7.692%)
Market Cap: £19.52m
AMP Live PriceLast checked at - London Stock Exchange

Intraday Ampeak Energy Share Chart

Offshore works completed at MeyGen site

18 Dec 2025 11:34

RNS Number : 1461M
Ampeak Energy Limited
18 December 2025
 

18 December 2025

 

 

 

AMPEAK ENERGY LIMITED

("Ampeak Energy" or the "Company")

 

 

Offshore works completed at MeyGen site

 

 

Ampeak Energy and Proteus Marine Renewables have successfully completed works at the world-leading MeyGen tidal stream project in Scotland's Pentland Firth.The offshore works involved three of the four turbines, and a series of inspection, maintenance and redeployment operations were successfully completed. Two of the three turbines (TTG 2 and TTG 4) were serviced offshore and returned to operation, whilst the third (TTG 1) was returned to Nigg for servicing and will be redeployed at a future date. No intervention was required on TTG 3, which has now accumulated seven years of operation, maintenance-free.  

 

Meygen is the largest tidal stream site in the world and has produced over 84 GWh of tidal energy, reinforcing its position as the world's number one tidal stream site and the home of the technology. With the site responsible for over 90% of the UK's tidal stream output, the team is focused on taking the lessons and experience to deliver a true large-scale tidal stream array.

 

With revenue support to take the site to 65MW capacity and planning to go all the way to c.400MW, Ampeak Energy, Proteus Marine Renewables Limited and the project partners are all focused on unlocking the true potential of the site and technology.

The successful completion of the latest offshore work demonstrates the strength of collaboration that is vital to MeyGen's and the industry's success.

Fraser Johnson, MeyGen Director of Operations & Assets, said:

 

"Collaboration is at the heart of industry, and these offshore operations were a great example of everyone coming together for the same outcome. I would like to thank all those involved in these successful efforts. Every step of the MeyGen journey is a step towards large-scale deployment and unlocking the full potential of tidal stream. For all involved, seeing firsthand the capabilities and opportunities makes it clear that tidal stream can and should play a major role in our energy future. It is predictable, scalable, and has the potential to be cost-competitive with other forms of predictable generation."

Drew Blaxland, Proteus CEO, said:

 

"The operation that we have just completed is another world record. Five turbine interventions in three days, without leaving site, servicing two of those on deck and returning them into operation subsea. Our continued works like this at MeyGen validate the commercial viability of subsea founded turbines. Our offshore services team works hand in hand with our turbine designers to ensure fit for purpose machines that can be handled safely and efficiently in high flow marine conditions. I am proud, not just of what has been achieved, but also of the professional manner in which it has been completed. Our low risk, repeatable and scalable methods help underpin tidal stream energy's bankable investment proposition."

 

 

 

 

 

 

 

For further information, please contact:

 

Ampeak Energy

Sean Parsons, Director of External Affairs

+44 (0)7739 832 446

Strand Hanson Limited (Nominated and Financial Adviser)

Richard Johnson

Rory Murphy

David Asquith

+44 (0)20 7409 3494

Zeus Capital Limited (Broker)

Louisa Waddell

Simon Johnson

 

+44 (0)20 3829 5000

 

Notes to Editors

 

Ampeak Energy is a global developer, owner and operator of sustainable energy projects. Ampeak Energy owns the world's flagship tidal stream project, MeyGen, and the Uskmouth Power Station site, which is being repurposed into a sustainable energy park that will become one of the UK's largest battery energy storage sites. www.ampeak.energy

 

Ampeak Energy's strategy: "Building a Sustainable Future to 2035", can be viewed here

 

Proteus Marine Renewables is a UK-based marine energy technology and offshore services provider with more than 20 years of tidal development heritage. Emerging from a 2022 management buyout, its ARSeries turbines have delivered over 20 GWh of clean power across 25 deployments worldwide. Proteus continues to advance tidal technology for global markets. https://proteusmr.com/

 

 

 

Proud to be part of London's universe of Green Economy Equities

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFZMMZMRZGKZM
Date   Source Headline
17th Feb 20267:06 amRNSTR-1 NOTIFICATION OF MAJOR HOLDINGS
17th Feb 20267:00 amRNSUltimate Beneficial Owner Notification
19th Jan 20269:31 amRNSMey BESS planning
18th Dec 202511:34 amRNS-ROffshore works completed at MeyGen site
20th Nov 20257:00 amRNSCCR funding completed
10th Nov 202510:34 amRNS-RAmpeak Energy welcomes Cabinet Secretary to MeyGen
4th Nov 20257:00 amRNS-RAmpeak Energy Investor Day
13th Oct 20259:08 amRNSAW2 Battery Project receives formal planning
7th Oct 20257:00 amRNSAmpeak Energy Investor Day
1st Oct 202512:46 pmRNSAmpeak Energy achieves planning permission for AW2
30th Sep 202510:23 amRNSDirector/PDMR Shareholding
26th Sep 20257:00 amRNSAmpeak Energy Interim Results
22nd Sep 202512:09 pmRNS-RAmpeak Energy hosts AW1 Groundbreaking Ceremony
31st Dec 20191:15 pmRNSAmphion Innovations
31st Dec 201912:36 pmRNSCancellation of trading on AIM
20th Nov 20197:00 amRNSDirectors' Dealings and Business Update
18th Oct 20197:00 amRNSSettlement of loan facility
11th Oct 20197:01 amRNSPolarean notes statement from Amphion Innovations
11th Oct 20197:00 amRNSSale of Partner Company Shares
3rd Oct 20197:00 amRNSSale of Partner Company Shares
25th Sep 20197:00 amRNSAmended Terms on Loan Facility
10th Sep 20194:56 pmRNSSale of Partner Company Shares
9th Aug 20194:14 pmRNSStatement on Amphion Innovations
9th Aug 20194:14 pmRNSDirectorate Change
9th Aug 20193:51 pmRNSSale of Partner Company Shares
1st Jul 20197:30 amRNSSuspension - Amphion Innovations Plc
27th Jun 20193:00 pmRNSAnnual Report and Accounts Update
14th Jun 20199:04 amRNSHolding(s) in Company
12th Jun 20197:00 amRNSLoan facility update
31st May 201910:28 amRNSHolding(s) in Company
20th May 20196:14 pmRNSHolding(s) in Company
1st Apr 20194:40 pmRNSSecond Price Monitoring Extn
1st Apr 20194:35 pmRNSPrice Monitoring Extension
1st Apr 20197:00 amRNSUpdate on Loan Facility
20th Mar 20197:00 amRNSHolding(s) in Company
19th Mar 20192:33 pmRNSSale of Partner Company Shares
18th Mar 20192:00 pmRNSPrice Monitoring Extension
15th Mar 20197:01 amRNSHolding(s) in Company
15th Mar 20197:00 amRNSSale of Partner Company Shares
11th Mar 20194:41 pmRNSAmended Terms on Loan Facility
26th Feb 20197:00 amRNSConvertible Promissory Note Extended
14th Feb 20198:00 amRNSStatement re. Motif Bio plc
7th Feb 20199:40 amRNSStmnt re Share Price Movement
1st Feb 20197:00 amRNSAppointment of Joint Broker
21st Jan 20197:00 amRNSWellGen Finalises License Agreement
11th Dec 20187:05 amRNSInvestment in Polarean & Loan Facility Repayment
16th Oct 20187:00 amRNSExtended Repayment and Draw Down on Loan Facility
28th Sep 20187:00 amRNSHalf-year Report
5th Sep 20187:00 amRNSBoard Change
23rd Aug 20183:20 pmRNSPolarean update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.